Treatment Action Group

Webinar series on the Global Ministerial Conference on TB

Treatment Action Group and the ACTION Global Health Advocacy Partnership will host a 2-part webinar series on civil society asks and engagement ahead of the Global Ministerial Conference on TB to be held on 16–17 November 2017 in Moscow, Russian Federation.

Read More →

No time to lose: G20 leadership in TB research needed to end TB

Treatment Action Group, Health GAP, AIDS-Free World, and Treatment Action Campaign urge G20 leaders to fund research to end TB.

Read More →

TAG statement on President’s 2018 budget blueprint

Treatment Action Group (TAG) released a statement in strong opposition to the President’s 2018 budget blueprint.

Read More →

Webinars on TB diagnostics and TB treatment now online

The European AIDS Treatment Group (EATG) and Treatment Action Group (TAG) hosted two webinars this month on TB diagnostics and TB treatment, respectively.

Read More →

Webinar on TB treatment

The European AIDS Treatment Group (EATG) and Treatment Action Group (TAG) will host a webinar on TB treatment on 13 March 2017 at 15:00 – 16:30 CET.

Read More →

Webinar on TB diagnostics

The European AIDS Treatment Group (EATG) and Treatment Action Group (TAG) will host a webinar on TB diagnostics on 6 March 2017 at 15:00 – 16:30 CET.

Read More →

An Activist’s Guide to Tuberculosis Diagnostic Tools

The guide provides an overview of the different tests and strategies for detecting TB and makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.

Read More →

TAG symposium: Stop Double Standards - videos now available online

The symposium was held October 27 at the 2016 Union World Conference on Lung Health in Liverpool, UK.

Read More →

Petition to BRICS countries to triple funding for TB R&D

>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response.

Read More →

Increasing funding for TB research: an advocacy strategy webinar

Cutting-edge science and research are critical to developing new tools to catalyze the end of tuberculosis (TB).  The US government plays a vital role in advancing research and development (R&D) for TB, as it is the largest supporter of TB R&D globally. Yet years of flat US government funding for TB R&D have eroded the prospect of new tests, treatments, and a vaccine to combat the rising threat of drug-resistant TB. Urgent advocacy and action are needed to maintain and increase US government funding for TB R&D.

Read More →

Page 2 of 9 · Total posts: 10

←First 1 2 3 Last→